Approximately one-fourth of new users in 2023 did not have type 2 diabetes
Ensuring medication access does not have to come at the cost of innovation
Stigma and misconceptions create barriers to medication uptake
Injectables were compared at doses approved for type 2 diabetes
For people with diabetes, cancer risks were reduced with GLP-1s versus insulin
Physicians must work to break this cycle of bias
Bupropion associated with least amount of weight gain
Prepare patients early for a time when medication is no longer an option
Moderate association between parental and offspring BMI at age 17
Childhood BMI nearly as important as adult BMI
Also in TTHealthWatch: managing obesity in children and adolescents
Zepbound met primary and secondary endpoints, with or without CPAP
Previous exposure to biologics, higher BMI, smoking all negatively linked to response
Final recommendations did not include weight-loss drugs